Cargando…

Expression and role of EGFR, cyclin D1 and KRAS in laryngocarcinoma tissues

Epidermal growth factor receptor (EGFR), cyclin D1 and KRAS proto-oncogene, GTPase (KRAS) genes serve roles in the occurrence and development of tumors. The aim of the current study was to investigate the expression levels of EGFR, cyclin D1 and KRAS in laryngocarcinoma tissues and their association...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Xinsheng, Wen, Guofeng, Wang, Shuangle, Lu, Hangui, Li, Chuangwei, Wang, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307426/ https://www.ncbi.nlm.nih.gov/pubmed/30651863 http://dx.doi.org/10.3892/etm.2018.7027

Ejemplares similares

Expression of endothelin-1 in laryngocarcinoma tissues and its clinical significance
por: WANG, SHAOZHONG, et al.
Publicado: (2016)

Liriodenine induces the apoptosis of human laryngocarcinoma cells via the upregulation of p53 expression
por: LI, LIANG, et al.
Publicado: (2015)

Chitosan-Based Glycolipid Conjugated siRNA Delivery System for Improving Radiosensitivity of Laryngocarcinoma
por: Miao, Jing, et al.
Publicado: (2021)

MiR‐29a‐3p suppresses cell proliferation in laryngocarcinoma by targeting prominin 1
por: Su, Jili, et al.
Publicado: (2017)

Strong nuclear EGFR expression in colorectal carcinomas is associated with cyclin-D1 but not with gene EGFR amplification
por: Dekanić, Andrea, et al.
Publicado: (2011)

Interactions between dendritic cells and T lymphocytes in pathogenesis of nasal polyps
por: Lin, Xinsheng, et al.
Publicado: (2018)

LncRNA MALAT1 Promote Cell Proliferation and Invasion by Sponging miR-125b to Modulate HMGA1 Expression in Laryngocarcinoma
por: Zong, Guangxin, et al.
Publicado: (2021)

EGFR and KRAS Mutations in Lung Parenchyma of Subjects With EGFR/KRAS Wild-Type Lung Adenocarcinoma
por: Chalela, Roberto, et al.
Publicado: (2021)

A mechanism for the response of KRAS(G13D) expressing colorectal cancers to EGFR inhibitors
por: McFall, Thomas, et al.
Publicado: (2020)

Cyclin D1 expression in KRAS mutant non-small cell lung cancer—old wine into new skins
por: Goh, Kah Yee, et al.
Publicado: (2020)

The prognostic values of EGFR expression and KRAS mutation in patients with synchronous or metachronous metastatic colorectal cancer
por: Huang, Ching-Wen, et al.
Publicado: (2013)

Differential Expression of RBM5, EGFR and KRAS mRNA and protein in non-small cell lung cancer tissues
por: Liang, Hong, et al.
Publicado: (2012)

Association between EGFR/KRAS mutation and expression of VEGFA, VEGFR and VEGFR2 in lung adenocarcinoma
por: Yuan, Xiao-Han, et al.
Publicado: (2018)

An essential role for Argonaute 2 in EGFR-KRAS signaling in pancreatic cancer development
por: Shankar, Sunita, et al.
Publicado: (2020)

Hypoxia-induced MIF induces dysregulation of lipid metabolism in Hep2 laryngocarcinoma through the IL-6/JAK-STAT pathway
por: Yang, Minlan, et al.
Publicado: (2022)

Characteristics and impact of postoperative surgical site infection on increased antibiotic duration among patients with laryngocarcinoma: a retrospective cohort study
por: Chen, Xinglong, et al.
Publicado: (2022)

KRAS and EGFR mutations coexisting in lung adenocarcinoma
por: Sousa, Vitor, et al.
Publicado: (2010)

EGFR and KRAS Mutations in Patients With Adenocarcinoma of the Lung
por: Jang, Tae Won, et al.
Publicado: (2009)

KRAS above and beyond – EGFR in pancreatic cancer
por: Siveke, Jens T., et al.
Publicado: (2012)

Feedback activation of EGFR/wild-type RAS signaling axis limits KRAS(G12D) inhibitor efficacy in KRAS(G12D)-mutated colorectal cancer
por: Feng, Juanjuan, et al.
Publicado: (2023)

Extensive rewiring of the EGFR network in colorectal cancer cells expressing transforming levels of KRAS(G13D)
por: Kennedy, Susan A., et al.
Publicado: (2020)

LOXL1-AS1 contributes to the proliferation and migration of laryngocarcinoma cells through miR-589-5p/TRAF6 axis
por: He, Guijun, et al.
Publicado: (2020)

EGFR Expression and KRAS and BRAF Mutational Status in Intestinal-Type Sinonasal Adenocarcinoma
por: Szablewski, Vanessa, et al.
Publicado: (2013)

Triptolide Induces Growth Inhibition and Apoptosis of Human Laryngocarcinoma Cells by Enhancing p53 Activities and Suppressing E6-Mediated p53 Degradation
por: Zhao, Fei, et al.
Publicado: (2013)

Role of Human Papilloma Virus 16/18 In Laryngeal Carcinoma with Correlation to the Expression of Cyclin D1, p53, p16 and EGFR
por: Tariq, Naila, et al.
Publicado: (2023)

Oleic acid-induced metastasis of KRAS/p53-mutant colorectal cancer relies on concurrent KRAS activation and IL-8 expression bypassing EGFR activation
por: Shen, Chih-Jie, et al.
Publicado: (2023)

PIK3CA Mutations Frequently Coexist with EGFR/KRAS Mutations in Non-Small Cell Lung Cancer and Suggest Poor Prognosis in EGFR/KRAS Wildtype Subgroup
por: Wang, Lei, et al.
Publicado: (2014)

The Role of EGFR/PI3K/Akt/cyclinD1 Signaling Pathway in Acquired Middle Ear Cholesteatoma
por: Liu, Wei, et al.
Publicado: (2013)

CRE: a cost effective and rapid approach for PCR-mediated concatenation of KRAS and EGFR exons: Rapid way to detect EGFR and KRAS mutations
por: Ramteke, Manoj P., et al.
Publicado: (2016)

Triple negative breast carcinoma EGFR amplification is not associated with EGFR, Kras or ALK mutations
por: Secq, V, et al.
Publicado: (2014)

Characterization of D-Cyclin Proteins in Hematolymphoid Neoplasms: Lack of Specificity of Cyclins D2 and D3 Expression in Lymphoma Subtypes
por: Metcalf, Ryan A, et al.
Publicado: (2010)

LINC00941 promoted in vitro progression and glycolysis of laryngocarcinoma by upregulating PKM via activating the PI3K/AKT/mTOR signaling pathway
por: Li, Zhihai, et al.
Publicado: (2022)

Evaluation on the Distribution of EGFR, KRAS and BRAF Genes and the Expression of PD-L1 in Different Types of Lung Cancer
por: Zhao, Rui, et al.
Publicado: (2021)

Effects of systemic administration of HESA-A on the expression of cyclin D1 and EGFR and E-cadherin in the induced tongue dysplasia in rats
por: Fattahi, Shirin, et al.
Publicado: (2017)

Perceived Poverty and Life Satisfaction in College Students with Impoverished Backgrounds: The Mediating Role of Self-Esteem
por: Liu, Bin, et al.
Publicado: (2022)

EGFR, PIK3CA, KRAS and BRAF mutations in meningiomas
por: BUJKO, MATEUSZ, et al.
Publicado: (2014)

A Radiogenomics Ensemble to Predict EGFR and KRAS Mutations in NSCLC
por: Moreno, Silvia, et al.
Publicado: (2021)

PEAK1, acting as a tumor promoter in colorectal cancer, is regulated by the EGFR/KRas signaling axis and miR-181d
por: Huang, Lanlan, et al.
Publicado: (2018)

Stapled peptide targeting the CDK4/Cyclin D interface combined with Abemaciclib inhibits KRAS mutant lung cancer growth
por: Bouclier, Celine, et al.
Publicado: (2020)

Role of cyclin D1 in breast carcinoma
por: Mohammadizadeh, Fereshteh, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_g7fk0c0uf9ima5sb4tbplv0ja0